July 22, 2008

IRX Therapeutics Announces Results of Phase 2 Study for IRX-2 - Businesswire.com

IRX Therapeutics Announces Results of Phase 2 Study for IRX-2 - Businesswire.com
NEW YORK–( BUSINESS WIRE )–IRX Therapeutics, a privately-held company dedicated to the discovery and development of proprietary therapies for the treatment of cancer and viral diseases, today announced preliminary findings from its Phase 2

Little girl succumbs to brain tumor - WWMT
OTSEGO, Mich. (NEWSCHANNEL 3) - There is a sad update to pass along to you. A little girl from Otsego who was battling a rare brain tumor passed away over the weekend. Kaylea Hatten was seven years old. Doctors found an inoperable tumor on her brain

New pill shrinks prostate tumors, study says - MSNBC
LONDON - A once-a-day pill significantly shrank tumors in men with advanced prostate cancer who had not responded to other treatments, researchers said on Tuesday. Cougar Biotechnology Inc's drug abiraterone delayed a worsening of the disease by a

CSA Medical Kills Cancer with Liquid Nitrogen Spray - Forbes
BALTIMORE, July 22 /PRNewswire/ — Two perfect strangers called, an ego was set aside, and technology to kill cancer was discovered, Timothy Askew, president, CSA Medical, told Greater Baltimore Committee members on July 10. "These strangers

IRX Therapeutics Announces Results of Phase 2 Study for IRX-2 - Earthtimes
NEW YORK - (Business Wire) IRX Therapeutics, a privately-held company dedicated to the discovery and development of proprietary therapies for the treatment of cancer and viral diseases, today announced preliminary findings from its Phase 2 clinical

Pharsight to Present On Modeling and Simulation At Quebec CPT World - MSN MoneyCentral
MOUNTAIN VIEW, Calif., July 22, 2008 (PRIME NEWSWIRE) — Pharsight Corporation (Nasdaq:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that two members of

Make-A-Wish grants Midland girl's dream - My West Texas
The brightly dressed rodeo clown hoisted 7-year-old Kali Rodriguez onto the cocoa-colored horse as she grabbed the saddle tightly and let out a slight smile. "It's almost wish day, hun," said Make-A-Wish's regional program services director Donna

Permalink • Print

Trackback uri

http://www.cancerresearchnewsonline.com/cancer-research-news/2008/07/22/irx-therapeutics-announces-results-of-phase-2-study-for-irx-2-businesswirecom/trackback/